tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Legend Biotech’s Earnings Call: Growth and Success
PremiumCompany AnnouncementsLegend Biotech’s Earnings Call: Growth and Success
1M ago
Legend Biotech price target raised to $77 from $75 at RBC Capital
Premium
The Fly
Legend Biotech price target raised to $77 from $75 at RBC Capital
1M ago
Positive Outlook for Legend Biotech: Strong Sales Growth and Strategic Advancements Drive Buy Rating
Premium
Ratings
Positive Outlook for Legend Biotech: Strong Sales Growth and Strategic Advancements Drive Buy Rating
1M ago
Legend Biotech’s Hold Rating: Balancing Strong Revenue Growth with Strategic Uncertainties
PremiumRatingsLegend Biotech’s Hold Rating: Balancing Strong Revenue Growth with Strategic Uncertainties
1M ago
Legend Biotech Reports Strong Q2 2025 Results and CARVYKTI® Success
Premium
Company Announcements
Legend Biotech Reports Strong Q2 2025 Results and CARVYKTI® Success
1M ago
Legend Biotech reports Q2 adjusted EPS 3c, consensus (20c)
Premium
The Fly
Legend Biotech reports Q2 adjusted EPS 3c, consensus (20c)
1M ago
Positive Growth Outlook for Legend Biotech Driven by Carvykti Sales and Strategic Expansion
PremiumRatingsPositive Growth Outlook for Legend Biotech Driven by Carvykti Sales and Strategic Expansion
2M ago
Strong Buy Rating for Legend Biotech’s CARVYKTI Amid Limited Competition and Favorable Risk Profile
Premium
Ratings
Strong Buy Rating for Legend Biotech’s CARVYKTI Amid Limited Competition and Favorable Risk Profile
2M ago
Legend Biotech price target lowered to $54 from $60 at UBS
Premium
The Fly
Legend Biotech price target lowered to $54 from $60 at UBS
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100